SUMMARY The diagnostic value of the Becton Dickinson Radioassay Kit (1251) 
During the development of folic acid (folate) deficiency a fall in the serum folate concentration precedes a fall in red cell folate concentration.' As the serum folate falls rapidly after cessation of folate intake,' however, a reduced serum folate is quite common in hospital patients2 who do not have a substantial reduction of folate stores. For this reason a red cell folate assay is often preferred for the detection of tissue depletion of folate.2 Both serum and red cell folate are almost entirely in the 5-methyltetrahydrofolate form, but serum folate is present as the monoglutamate (folic acid) while red cell folate is present as polyglutamates 'which must be converted to the monoglutamate before assay. Serum, red cell, and whole blood folate may be measured by microbiological assay; Lactobacillus casei is the organism most often used.34 Microbiological assays are labour intensive, however, and are prone to periodic failure. This has led to attempts to develop radioisotopic competitive protein binding assays.>-7
In a detailed assessment of a widely used commercially available kit for the assay of red cell folate by competitive protein binding we have found the performance to be acceptable with regard to precision and specificity and good with regard to sensitivity. But the assay was non-linear with changing packed cell volume.
Accepted for publication 8 May 1984 Material and methods A competitive protein binding radioassay of red cell folate (folic acid) was carried out using the Becton Dickinson Radioassay Kit (125I) which uses a protein binder derived from milk and iodine '25-labelled pteroylglutamic acid (folic acid). The assay was performed as specified by the manufacturer. It requires (a) During the study a deoxyuridine suppression test was also performed on all patients who were having bone marrow aspirates for the investigation of macrocytosis, regardless of the most likely cause of the macrocytosis. The dietary intake of vitamin B,2, folic acid, ascorbic acid, and iron was assessed by a dietician in patients with megaloblastic anaemia in whom the cause was not readily apparent or in whom the clinical staff suspected a dietary deficiency. Small bowel biopsies and other investigations for malabsorption were carried out when clinically indicated. After full assessment patients were classified using the criteria shown in the Table, excluding any consideration of red cell folate concentration.
Assays were also carried out on 22 samples from patients taking phenytoin sodium, who were not otherwise investigated. In addition, in order to assess the specificity of the assay samples were collected from 50 haematologically normal inpatients. These patients had mean cell volumes of less than 96 fl and haemoglobin concentrations greater than 13 g/dl (men) or 11-5 g/dl (women). They were selected to include equal numbers of men and women and equal numbers of medical and surgical patients.
Those who had recently been transfused were excluded; in other respects they were unselected.
Results

PRECISION
Coefficients of variation of the red cell folate assay on paired samples were 12% within batch and 26% between batch (two assays). For folate, if expressed per unit volume of red cells, Of the 50 patients selected as being unlikely to be approximates closely to a measure of red cell folate, folate deficient, four (8%) had folate concentrations and many laboratories therefore do not correct red below the normal range and none had values falling cell folate assay results for the folate contributed by below 100 ug/l (Fig. 3) . The mean value was serum rather than red cells. In the present study the significantly lower than the mean value in normal consequent overestimation of the red cell folate volunteers (p < 0.01).
concentration in normal subjects averaged 2-1%. Since measurement of the serum folate concentration on every sample would double the size and cost of each assay we have chosen to assess the precision, accuracy, sensitivity, and specificity of an uncorrected red cell folate assay.
We have found red cell folate values determined by a competitive protein binding radioassay to have a logarithmic distribution in normal subjects with no difference between men and women and with a reference range similar to ranges for microbiological assays. Our reference range of ,g/l differs considerably from that stated by the manufacturer (124-600 ,ug/l), which also represents 95% confidence limits and is based on "over 120 healthy volunteers" from three parts of the USA. This difference underlines the importance of each laboratory deriving its own reference range; had we interpreted patient data by comparison with the manufacturer's range quite different conclusions would have been drawn. Precision of the red cell folate assay on paired samples was acceptable, though inferior to the precision claimed for serum folate assay with the same kit (manufacturer's notes), and inferior to precision previously reported for microbiological assays. The overestimation of red cell folate concentration at all packed cell volumes, with the proportionately greater effect at low packed cell volumes, indicates a defect in the competitive protein binding assay for folate. Despite this undesirable feature the assay successfully separates folate deficient subjects, many of whom have low packed cell volumes, from normal subjects. As with microbiological folate assays the radioassay fails to separate effectively folate deficient patients from vitamin B12 deficient patients. Specificity of the assay was less satisfactory than sensitivity.
